IBE
print


Navigationspfad


Inhaltsbereich

Lindörfer

Publikationen | Vorträge | Poster

Publikationen

 

  • Lindoerfer D, Mansmann U. Enhancing Requirements Engineering for Patient Registry Software Systems with Evidence-based Components. J Biomed Inform. 2017 May 20. pii: S1532-0464(17)30109-0. doi: 10.1016/j.jbi.2017.05.013. [Epub ahead of print] - Temporary Link
  • Lindoerfer D, Mansmann U. IT Infrastructure of an Oncological Trial Where Xenografts Inform Individual Second Line Treatment Decision. Stud Health Technol Inform. 2017;235:226-230.
  • Lindoerfer D, Mansmann U. Proposing an Evidence-Based Strategy for Software Requirements Engineering. Stud Health Technol Inform. 2016;228:648-52.
  • Lindoerfer D, Mansmann U. A Comprehensive Assessment Tool for Patient Registry Software Systems: The CIPROS Checklist. Methods Inf Med. 2015 Oct 12;54(5):447-54. doi: 10.3414/ME14-02-0026. Epub 2015 Sep 30.
  • Hoffmann VS, Baccarani M, Hasford J, Lindoerfer D, Burgstaller S, Sertic D, Costeas P, Mayer J, Indrak K, Everaus H, Koskenvesa P, Guilhot J, Schubert-Fritschle G, Castagnetti F, Di Raimondo F, Lejniece S, Griskevicius L, Thielen N, Sacha T, Hellmann A, Turkina AG, Zaritskey A, Bogdanovic A, Sninska Z, Zupan I, Steegmann JL, Simonsson B, Clark RE, Covelli A, Guidi G, Hehlmann R. The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries. Leukemia. 2015 Jun;29(6):1336-43. doi: 10.1038/leu.2015.73. Epub 2015 Mar 18.
  • Lindoerfer D, Mansmann U. CIPROS – A checklist with items for a patient registry software system. Stud Health Technol Inform. 2014;205:161-5.
  • Hoffmann VS, Baccarani M, Lindoerfer D, Castagnetti F, Turkina A, Zaritsky A, Hellmann A, Prejzner W, Steegmann JL, Mayer J, Indrak K, Colita A, Rosti G, Pfirrmann M. The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib. Leukemia. 2013 Oct 27; (10):2016-22. doi: 10.1038/leu.2013.171. Epub 2013 Jun 11.
  • Hoffmann V, Baccarani M, Hasford J, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R. The EUTOS CML score aims to support clinical decision-making. Blood. 2012 Mar 22; 119(12):2966-7.
  • Dietz C, Simonsson B, Baccarani M, Guilhot J, Hasford J, Lindörfer D, Hoffmann V, Rosti G, Schuld P, Piccolo C, Castellano G, Hehlmann R, Pane F, Cervantes F, Müller M, Cross N, Hochhaus A, Saußele S: Latest News about EUTOS. In European Leukemia Net (ELN) Informationletter No8, February 2012.
  • Verena Hoffmann, Joerg Hasford, Susanne Saussele, Doris Lindörfer, Markus Pfirrmann, Rüdiger Hehlmann: Der EUTOS Score: Vorhersage von kompletter zytogenetischer Remission und progressionsfreiem Überleben bei CML Patienten unter Imatinibtherapie. Leukämie Rundbrief 16, Dezember 2011: 11-12.
  • Hasford J, Baccarani M, Hoffmann V, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R. Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment. The EUTOS score. Blood. 2011 Jul 21; 118(3):686-92. Epub 2011 May 2.
  • Baccarani M, Guidi G, Guilhot J, Hasford J, Hehlmann R, Lindoerfer D, Pfirrmann M, Piccolo C, Saussele S, Schuld P, Schrotz-King P and Simonsson B: The EUTOS for CML Registry, the first of its kind in CML: measuring Quality of Care. In European Leukemia Net (ELN) Informationletter, No7, February 2011.nach oben

Vorträge

  • Lindoerfer D, Mansmann U. IT Infrastructure of an Oncological Trial Where Xenografts Inform Individual Second Line Treatment Decision. Informatics for Health 2017 / 24 – 26 April 2017 Manchester, UK. Paper and Talk
  • Lindoerfer D, Mansmann U. Proposing an Evidence-Based Strategy for Software Requirements Engineering. HEC 2016 – Health - Exploring Complexity: An Interdisciplinary Systems Approach. 28. August – 2. September 2016. Munich, Germany. Paper and Talk
  • Lindoerfer D, Mansmann U. A proposal of Checklist Items for evaluating a patient registry software system. 59. GMDS-Jahrestagung, 07.-10. September 2014, Göttingen. Abstract und Vortrag
  • Lindoerfer D, Mansmann U. CIPROS – A checklist with items for a patient registry software system. MIE 2014 – XXV Conference of the European Federation for Medical Informatics, 31 August - 3 September 2014, Istanbul, Turkey. Paper and Talk
  • Lindörfer D. Characteristics of CML at diagnosis: a comparison of in-study, out-study, and population-based registry patients. 23rd International CML-Workshop and EUTOS-Meeting, June 27-28, 2014, Mannheim. Talk
  • Lindoerfer D, Hoffmann VS, Rosti G, Castagnetti F, Saussele S, Guilhot J, Simonsson B, Steegmann JL, Mayer J, Indrak K, Turkina AG, Zaritskey A, Labar B, Zupan IP, Thielen N, Clark RE, Thaler J, Melanthiou F, Everaus H, Porkka K, Bogdanovic AD, Schubert-Fritschle G, Panagiotidis P, Masszi T, Lejniece S, Griskevicius L, Hellmann A, Prejzner W, Sacha T, Almeida A, Dyagil I, Colita A, Mihaylov G, Hehlmann R, Hasford J, Baccarani M. The EUTOS Population-based registry: Evaluation of baseline characteristics and first treatment choices of 2978 newly diagnosed chronic myeloid leukemia (CML) patients from 20 European countries. Haematologica 2014; 99(s1):247-8: EHA abstract no. S680. 19th Congress of the European Hematology Association, Milan, Italy, June 12 - 15, 2014. Abstract and Talk
  • Pfirrmann M, Saussele S, Baccarani M, Guilhot J, Cervantes F, Ossenkoppele G, Lindoerfer D, Hoffmann VS, Castagnetti F, Hehlmann R, Simonsson B. OVERALL SURVIVAL AND PROGNOSIS IN 2190 PATIENTS WITH FIRST-LINE IMATINIB TREATMENT CONSIDERING DEATH DUE TO CHRONIC MYELOID LEUKAEMIA AS THE ONLY EVENT. Haematologica 2014; 99(s1):532: EHA abstract no. S1360. 19th Congress of the European Hematology Association, Milan, Italy, June 12 - 15, 2014. Abstract and Talk
  • Lindörfer D. The EUTOS CML registries – status quo. 21st International CML-Workshop / EUTOS-Meeting, June 29-30, 2012, Mannheim. Talk
  • Saussele S, Lauseker M, Hoffmann V, Lindörfer D, Hanfstein B, Proetel U et al. The EUTOS high-risk population differs substantially from the EURO score high-risk group; the EUTOS score predicts molecular response in chronic phase CML patients: results of the German CML-Study IV. Haematologica 2012;97(s1):EHA abstract no. 1105, Abstract and Talk
  • Hoffmann V, Hasford J, Baccarani M, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R. A new prognostic model for chronic myeloid leukaemia patients: The EUTOS score. DGHO Jahrestagung 30. September - 04.Oktober 2011, Basel. Abstract und Vortrag
  • Hoffmann V, Lindörfer D, Pfirrmann M für die EUTOS CML Registergruppe. Entwicklung eines neuen Prognosemodells für Patienten mit chronischer myeloischer Leukämie (CML) aus dem Register der European Treatment and Outcome Study (EUTOS): Vereinfachung eines logistischen Regressionsmodells und Split-Sample-Methode. GMDS-Jahrestagung, 25.-28. September 2011, Mainz. Abstract und Vortrag
  • Baccarani M, Hasford J, Hoffmann V, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R. A new prognostic Score (EUTOS Score). Predicting complete cytogenetic response and progression-free survival in 2060 patients with chronic myeloid leukemia on imatinib treatment. 16th Congress of EHA in London, June 9-12 2011. Abstract and Talk
  • Lindörfer D, Müller TH. Integration und Analyse von Patienten mit Chronischer Myeloischer Leukämie (CML) in 25 Europäischen Ländern mit webbasierter elektronischer Datenerfassung. 55. GMDS –Jahrestagung, 05.-09. September 2010, Mannheim. Abstract und Vortrag
  • Hoffmann V, Lindörfer D: Berichterstattung von Zensierungsmechanismen in Veröffentlichungen zu Randomisierten klinischen Studien. 53. Jahrestagung der GMDS, September 15-18, Stuttgart. Abstract und Vortragnach oben

Poster

  • Baccarani M, Hoffmann VS, Rosti G, Castagnetti F, Saussele S, Guilhot J, Simonsson B, Steegmann JL, Mayer J, Indrak K, Turkina AG, Zaritskey A, Labar B, Zupan I, Thielen N, Clark RE, Thaler J, Melanthiou F, Everaus H, Porkka K, Bogdanovic A, Schubert-Fritschle G, Panagiotidis P, Masszi T, Lejniece S, Griskevicius L, Hellmann A, Prejzner W, Sacha T, Almeida A, Dyagil I, Colita A, Mihaylov GG, Hehlmann R, Hasford J, Lindoerfer D. Baseline Characteristics of CML Patients Accross Europe - Comparing Real-World Patients with Patient Collectives Included in Clinical Trials. 56th ASH Annual Meeting and Exposition, December 6-9, 2014. San Francisco, CA. Abstract and Poster
  • Hoffmann VS, Lindoerfer D, Thaler J, Labar B, Melanthiou F, Mayer J, Everaus H, Guilhot J, Schubert-Fritschle G, Castagnetti F, Lejniece S, Griskevicius L, Thielen N, Sacha T, Hellmann A, Turkina AG, Zaritskey A, Bogdanovic A, Indrak K, Zupan I, Steegmann JL, Simonsson B, Clark RE, Hoglund M, Hehlmann R, Hasford J, Baccarani M. Incidence of CML in Europe - a Comparison of 19 European Countries with US SEER Data. 56th ASH Annual Meeting and Exposition, December 6-9, 2014. San Francisco, CA. Abstract and Poster
  • Hoffmann V, Lindoerfer D, Thaler J, Labar B, Melanthiou F, Mayer J, Everaus H, Porkka K, Guillhot J, Schubert-Fritschle G, Castagnetti F, Lejniece S, Griskevicius L, Thielen N, Hellmann A, Turkina A, Zaritskey A, Bogdanovic AD, Indrak K, Zupan IP, Casado LF, Simonsson B, Clark RE, Hehlmann R, Hasford J, Baccarani M. The EUTOS Population-based Registry – Incidences of CML across Europe. Haematologica 2014; 99(s1):74: EHA abstract no. P274. 19th Congress of the European Hematology Association, Milan, Italy, June 12 - 15, 2014. Abstract and Poster
  • Hoffmann VS, Lindoerfer D, Pfirrmann M, Saussele S, Hochhaus A, Engel J, Guilhot J, Rosti G, Mayer J, Indrak K, Castagnetti F, Turkina A, Zaritskey A, Steegmann JL, Hellmann A, Thielen N, Cervantes F, Simonsson B, Colita A, Clark RE, Almeida A, Labar B, Marin D, Ossenkoppele GJ, Bogdanovic A, Dyagil I, Porkka K, O'Brien S, Griskevicius L, Panagiotidis P, Thaler J, Zupan I, Lejniece S, Everaus H, Masszi T, Melanthiou F, Hehlmann R, Hasford J and Baccarani M. CML Patients In Clinical Trials Represent Fairly Well The General Population Of CML Patients: A Comparative Analysis Of 5803 Patients From The EUTOS Registry. 55th ASH Annual Meeting and Exposition, December 7-10, 2013, New Orleans, LA. Abstract and Poster
  • Hoffmann V, Mayer J, Turkina A, Hellmann A, Indrak K, Steegmann JL, Zaritskey A, Colita A, Lindoerfer D, Baccarani M. EUTOS Score Is Also Valid in CML Patients Not Involved in Clinical Studies. 54th ASH Annual Meeting and Exposition, December 8-11, 2012, Atlanta. Abstract and Poster
  • Lindörfer D, Müller TH. A query tool for an electronic data capture patient registry software system. XXIV Conference of the European Federation for Medical Informatics, 26-29 August 2012, Pisa, Italy. Abstract and Poster
  • Saußele S, Hoffmann V, Lindörfer D, Hochhaus A, Cervantes F, Ossenkoppele G, Hjorth-Hansen H, O'Brien S, Mayer J, Indrak K, Hellmann A, Colita A, Turkina A, Zaritskey A, Steegman JL, Marin D, Pfirrmann M, Baccarani M, Guilhot J, Hasford J, Piccolo C, Simonsson B, Hehlmann R, Rosti G. Outcome of patients with chronic myeloid leukemia after allogeneic stem cell transplantation in Europe; data from the EUTOS for CML registry. 53rd ASH Annual Meeting and Exposition, December 10-13, 2011, San Diego. Abstract and Poster
  • Lindörfer D, Hoffmann V, Müller TH. Europaweite Integration und Analyse von Patienten mit chronischer myeloischer Leukämie (CML). 56. GMDS-Jahrestagung, 25.-28. September 2011, Mainz. Abstract und Poster
  • Hasford J, Almeida A, Baccarani M, Bogdanovic A, Clark R, Colita A, Costeas P, Demeckova E, Dyagil I, Everaus H, Griskevicius L, Guilhot J, Hehlmann R, Hellmann A, Hoffmann V, Indrak K, Koskenvesa P, Labar B, Lejniece S, Lindoerfer D, Ossenkoppele G, Panagiotidis P, Rosti G, Simonsson B, Steegmann J, Thaler J, Turkina A, Zackova D, Zaritskey A, Zupan I. The European Population-based CML Registry Objectives and First Results. 16th Congress of EHA in London, June 9-12 2011. Abstract und Poster
  • Schrotz-King P, Hasford J, Lindörfer D, Piccolo C, Pfirrmann M, Engel J, Schubert-Fritschle G, Saussele S, Kossak U, Hochhaus A, Guilhot J, Baccarani M, Simonsson S, Hehlmann R, EUTOS for CML. A population based registry in chronic myeloid leukaemia (CML), a network of registries covering “representative” areas or regions of Europe (<10 million people). DGHO Jahrestagung, 1.-5.Oktober 2010 Berlin. Abstract und Poster
  • Hasford J, Rosti G, Lindoerfer D, Baccarani M, Guilhot J, Montrucchio L, Rancati F, Simonsson B, Nicolini F, Ossenkoppele G, Hehlmann R. Outcome and Prognosis of 1955 Patients with Chronic Myeloid Leukemia: First Results of the CML-Registry of the European Treatment and Outcome Study EUTOS. 51st ASH Annual Meeting and Exposition, December 5-8, 2009, New Orleans. Abstract and Poster
  • Baccarani M, Simonsson B, Lindörfer D, Rosti G, Almeida AM, Bogdanovic A, Clark RE, Colita A, Costeas PA, Griskevicius L, Guilhot J, Hellmann A, Indrak K, Laane E, Labar B, Masszi T, Lejniece S, Mayer J, Ossenkoppele G, Panayiotidis P, Porkka K, Saussele S, Hochhaus A, Steegmann JL, Thaler J. Turkina A, Verhoef G, Zaritskey A, Zupan I, Rancati F, Montrucchio L, Hehlmann R and Hasford J. The European Treatment and Outcome Study (EUTOS) for Chronic Myeloid Leukemia (CML). A Prospective, Population-Based European Registry. 51st ASH Annual Meeting and Exposition, December 5-8, 2009, New Orleans. Abstract
  • Hoffmann V, Lindörfer D: Reporting of censoring in randomised clinical trials. 29th Annual Conference of the International Society for Clinical Biostatistics, August 17-21, Copenhagen, Denmark. Abstract und Poster